Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference35 articles.
1. Ferrante di Ruffano L, Davenport C, Eisinga A, Hyde C, Deeks JJ. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. J Clin Epidemiol. 2012;65:282–7.
2. Ferrante di Ruffano L, Harris IM, Zhelev Z, Davenport C, Mallett S, Peters J, et al. Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organisations. medRxiv. 2022;31:154.
3. Chen G, Peirce V, Marsh W. Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program decisions: incremental cost-effectiveness ratio thresholds and decision-modifying factors. Value in Health. 2020;23:1300–6.
4. van der Pol S, Rojas Garcia P, Antoñanzas Villar F, Postma MJ, van Asselt ADI. Health-economic analyses of diagnostics: guidance on design and reporting. Pharmacoeconomics. 2021;39:1355–63.
5. Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force. Value in Health. 2022;25:10–31.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献